WDGJF yields 512.82% · JNJ yields 2.13%● Live data
📍 WDGJF pulled ahead of the other in Year 1
Combined, WDGJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WDGJF + JNJ for your $10,000?
John Wood Group PLC, together with its subsidiaries, provides consulting, project management, and engineering solutions to energy and built environment worldwide. It operates through four segments: Projects, Operations, Consulting, and Investment. The company offers engineering solutions, including decarbonization and optimization in energy and industry; and renewable energy, future fuels, and low carbon solutions. It also provides environment and infrastructure solutions comprising environmental studies and compliance, environmental remediation, public infrastructure, and geotechnical and materials services; clean energy solutions; mine planning and design, mineral processing and metallurgy, mineral resources and project assessment services; and automation and control solutions, such as asset protection and facility and process automation solutions, as well as simulation, learning, and virtual systems. In addition, the company offers subsea and export systems, including subsea, umbilical, riser, and flowline design, as well as planning, design, and development of marine terminals and pipelines; and hull and marine services. It serves oil and gas, infrastructure, industrial and manufacturing, mining, power, and government sectors. John Wood Group PLC was incorporated in 1961 and is headquartered in Aberdeen, the United Kingdom.
Full WDGJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.